Analysis of adverse reactions with phenytoin and carbamazepine in tertiary care hospital – A retrospective study

Introduction: Drugs used in pharmacotherapy are known to cause adverse reactions along with its useful therapeutic effects. Pharmacotherapy is the common modality of treatment for seizures and epilepsies. Despite the availability of many pharmacotherapeutic agents for the management of epilepsies, e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Perspectives in medical research 2019-04, Vol.7 (1), p.75-78
1. Verfasser: Syed Arshaduddin Ahmed1 , Mohammed Abid Ali2 , T S Usha Sree3 , Margaret Viola4 , Shaima Zafer Khan 5
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction: Drugs used in pharmacotherapy are known to cause adverse reactions along with its useful therapeutic effects. Pharmacotherapy is the common modality of treatment for seizures and epilepsies. Despite the availability of many pharmacotherapeutic agents for the management of epilepsies, even today the broad spectrum anti-epileptic drugs like phenytoin and carbamazepine are frequently prescribed owing to their effectiveness. Here with this retrospective study an attempt has been made to understand the different adverse reactions developed especially serious reactions with the phenytoin and carbamazepine. Materials and Methods: It’s a retrospective study; data is collected from case sheets and adverse drug reaction reporting forms. Results: In this retrospective study we noted serious reactions like Stevens Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Out of 100 reactions studied 72% are with phenytoin and 28% are with carbamazepine. Conclusion: The study is intended to project the seriousness of adverse reactions with commonly prescribed anti-epileptic drugs. There is a need for further studies especially prospective safety and efficay studies
ISSN:2348-1447
2348-229X